Skip to main content
OpenTrials

Clinical trial condition

Lymphoma

Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.

3,652 public trials 850 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma trial results

Completed

A Study of ONTAK and CHOP in Newly Diagnosed, Peripheral T-Cell Lymphoma

NCT00211185

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Birmingham Hematology and Oncology Birmingham, Alabama, United States
  • Hematology Oncology Associates Phoenix, Arizona, United States
  • Stanford Cancer Center Stanford, California, United States
  • Rocky Mountain Cancer Center Denver, Colorado, United States
View all 49 locations
View Trial Details
Completed

A Study Of PF-05082566 As A Single Agent And In Combination With Rituximab

NCT01307267

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +45 more
Locations
  • City of Hope Duarte, California, United States
  • UC San Diego Moores Cancer Center-Investigational Drug Services La Jolla, California, United States
  • UC San Diego Medical Center-La Jolla (Jacobs Medical Center/Thornton Hospital) La Jolla, California, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
View all 42 locations
View Trial Details
Completed

Panobinostat and Everolimus in Treating Patients With Recurrent Multiple Myeloma, Non-Hodgkin Lymphoma, or Hodgkin Lymphoma

NCT00918333

Conditions
Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +75 more
Locations
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Mark O Hatfield-Warren Grant Magnuson Clinical Center Bethesda, Maryland, United States
  • Mayo Clinic Rochester, Minnesota, United States
View Trial Details
Completed

Clinical Study Assessing Outcomes, Adverse Events, Treatment Patterns, and Quality of Life in Patients Diagnosed With Mycosis Fungoides Cutaneous T-cell Lymphoma

NCT02296164

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • Investigator Site Little Rock, Arkansas, United States
  • Investigator Site Duarte, California, United States
  • Investigator Site La Mesa, California, United States
  • Investigator Site San Francisco, California, United States
View all 36 locations
View Trial Details
Completed

A Multiple Ascending Dose Study of MEDI7247 in Patients With Selected Relapsed/Refractory Hematological Malignancies

NCT03106428

Conditions
Acute Myeloid Leukemia, Blood Protein Disorders, Cardiovascular Diseases, +22 more
Locations
  • Research Site Los Angeles, California, United States
  • Research Site Denver, Colorado, United States
  • Research Site Atlanta, Georgia, United States
  • Research Site Chicago, Illinois, United States
View all 14 locations
View Trial Details

Related conditions